Couverture de Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

De : Julio G. Martinez-Clark
Écouter gratuitement

À propos de ce contenu audio

Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.


What You’ll Learn:

  • Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.
  • Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.
  • Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.


Why Listen?

  • Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.
  • Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.
  • Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.

“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay.


This podcast is why we partnered with them.”
– Digital Health Startup CEO


New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.


Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.

© 2026 Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Direction Economie Hygiène et vie saine Maladie et pathologies physiques Management et direction
Épisodes
  • Gary Zammit, President & CEO at Clinilabs Drug Development Corporation

    Gary Zammit, President & CEO at Clinilabs Drug Development Corporation
    Apr 17 2026

    In this episode, we welcome Gary K. Zammit, a leading expert at the intersection of science, business, and innovation in the life sciences industry.

    Gary is the founder and CEO of Clinilabs, a CNS-focused contract research organization, and the author of Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences. He also serves as a clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai and is a fellow of the American Academy of Sleep Medicine.

    With more than 250 published articles and abstracts, Gary has spent his career advancing safer and more effective treatments for psychiatric and neurological disorders. In this conversation, he shares insights from decades of experience—exploring how scientific rigor, operational excellence, and human-centered leadership come together to transform healthcare innovation.

    Tune in for a deep dive into the future of clinical research, entrepreneurship in life sciences, and the systems that drive meaningful impact.
    Afficher plus Afficher moins
    46 min
  • Joseph Grieco, VP at Tris Pharma & Liza Micioni, Sr. Director at Tris Pharma

    Joseph Grieco, VP at Tris Pharma & Liza Micioni, Sr. Director at Tris Pharma
    Apr 10 2026

    In this episode, we speak with Joseph Grieco and Liza Micioni, two experienced leaders in clinical development.

    Joseph Grieco leads clinical programs in neurological disorders at Tris Pharma, focusing on innovative solutions for unmet medical needs.

    Liza Micioni brings over 25 years of experience in global clinical operations, specializing in rare diseases and CNS disorders, with a strong focus on patient-centric approaches.

    Together, they discuss how leadership, innovation, and operational excellence are shaping the future of clinical research.
    Afficher plus Afficher moins
    53 min
  • Robert Packard, President at Medical Device Academy, Inc

    Robert Packard, President at Medical Device Academy, Inc
    Mar 27 2026

    In this episode, we are joined by Robert Packard, a seasoned Quality and Regulatory Affairs professional with over 20 years of experience in the medical device industry and a decade in biotech manufacturing validation and scale-up.

    Robert has held leadership roles in multiple startups, co-founded a laparoscopic imaging company, and previously worked as a lead auditor and instructor for a major Notified Body. His expertise spans 510(k) submissions, CE Marking, Canadian Medical Device Licensing, and the development and implementation of ISO 13485-compliant quality systems.

    He is also passionate about education, producing weekly training content focused on current quality and regulatory challenges.
    Afficher plus Afficher moins
    53 min
Aucun commentaire pour le moment